239 participants
Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-16
- Start Date:
- 2009-10-31
- Completion:
- 2012-01-31
Conditions
- Cytomegalovirus Infection
Interventions
- DRUG